NIH-supported clinical trial shows AI tool as effective as healthcare providers in generating referrals to addiction specialists.

In March 2025, Coordination Pharmaceuticals Inc. announced a phase 1b/2a Study of RiMO-301 and Hypofractionated Radiotherapy With A PD-1 Inhibitor for the Treatment of Unresectable, Recurrent or ...

In March 2025, Juventas Cell Therapy Ltd. conducted a phase Ib/II trial to evaluate the safety and efficacy of CNCT19 ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic rhinosinusitis.

Examine the top cyber and risk threats and opportunities facing health care in 2025 in this blog by John Riggi, AHA’s ...

Research finds adults under 70 with atrial fibrillation have 21% higher dementia risk, with onset cases showing a dramatic 36 ...

Is clinical trial representation fair? Learn why disease incidence matters more than Census data for health equity.

A multicenter study led by Cedars-Sinai created a database of adverse medication events—the fourth leading cause of death in ...

Editas Medicine struggles with underwhelming data and lacks major partnerships. Find out why EDIT stock faces significant ...

The 2025 Industry Outlook suggests that while organizations are continuing to experiment with AI use cases, the fervor indicated in last year's report is waning. Fewer experts are in the exploratory ...

This article examines post-market drug safety, highlighting surveillance mechanisms, regulatory responses, and case studies of approved drugs with hidden risks.